Chemclin Raises $16.5 Million
Chemclin, a Beijing-based medical diagnostics company, has raised $16.5 million in Series B funding. China Healthcare Partnership (managed by MC China) led the round, and was joined by return backers WI Harper, Siemens Venture Capital and Softbank China Venture Capital. China eCapital served as placement agent. The company had previously raised $5 million.
20 October 2008•6 mins read
